A5018164196- Hepatitis C virus research
- COVID-19 and healthcare impacts
- Pericarditis and Cardiac Tamponade
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Myasthenia Gravis and Thymoma
- Pharmaceutical studies and practices
- Abdominal vascular conditions and treatments
- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Infective Endocarditis Diagnosis and Management
- Diverse Scientific Research Studies
- Takotsubo Cardiomyopathy and Associated Phenomena
- Liver Disease Diagnosis and Treatment
- COVID-19 diagnosis using AI
- Gastrointestinal Bleeding Diagnosis and Treatment
- Lipid metabolism and disorders
- Sepsis Diagnosis and Treatment
- Eosinophilic Disorders and Syndromes
- Inflammasome and immune disorders
- Hepatitis B Virus Studies
- Cancer, Lipids, and Metabolism
ASST Fatebenefratelli Sacco
2021-2023
University of Milan
2023
Fatebenefratelli Hospital
2021-2023
Azienda Ospedaliera Fatebenefratelli e Oftalmico
2022
Sapienza University of Rome
2012
Familial combined hypolipidemia causes a global reduction of plasma lipoproteins. Its clinical correlates and metabolic implications have not been well defined. The objective the study was to investigate genetic, clinical, characteristics cohort subjects with familial hypolipidemia. design included candidate gene screening comparison between carrier noncarrier individuals. conducted in general community. Participants individuals belonging nine families identified small town (Campodimele) as...
During the COVID-19 2020 outbreak, a large body of data has been provided on general management and outcomes hospitalized patients. Yet, relatively little is known characteristics outcome patients managed in Internal Medicine Units (IMU). To address this gap, Italian Society conducted nationwide cohort multicentre study death adult admitted IMU. This assessed 3044 at 41 referral hospitals across Italy from February 3rd to May 8th 2020. Demographics, comorbidities, organ dysfunction,...
The World Health Organization (WHO) goal of hepatitis C virus (HCV) elimination by 2030 relies on the scaling-up both identification and linkage to care infected population, worldwide. In Italy, estimated burden HCV carriers who are unaware their infection amounts 200 000 persons, a projection that reinforces need for broadening population access effective screening programmes.A pivotal programme targeting subjects born between 1969 1989 has been conducted in Lombardy, Northern where...
Abstract Aims To identify peripheral blood cellular correlates of active pericarditis and to verify whether neutrophils, lymphocytes the neutrophil to‐lymphocyte ratio (NLR) are associated with disease phenotype or prognosis. Methods Observational prospective study on a cohort 63 patients idiopathic followed for 12 months after each recurrence. Two distinct analyses were performed: “index attack” analysis focused first episode in patient, while “all attacks” included all episodes occurring...
<h3>Background:</h3> The powerful drugs with direct antiviral action (DAA) against hepatitis C virus (HCV) has made it possible to eliminate the trigger factor of Mixed Cryoglobulin Syndrome (MCS) and extend treatment patients who could not tolerate IFN-based regimens. However, persistence cryoglobulin production MCS-related symptoms despite SVR achievement is frequently reported. <h3>Objectives:</h3> aim this study was assess persistency rate clinical laboratory indexes after successful...
A surprising improvement in COVID-19 chest CT follow up gives hope regarding future clinical evolution of patients.